Embecta Corp.

Embecta Corp.

EMBC·NASDAQ

$3.32

-2.8%
HealthcareDrug Manufacturers - Specialty & Generic

Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety devices, as well as digital applications to assist people with managing their diabetes. The company primarily sells its products to wholesalers and distributors in the United States and internationally. Embecta Corp. was founded in 1924 and is based in Parsippany, New Jersey. Embecta Corp.(NasdaqGS:EMBC) operates independently of Becton, Dickinson and Company as of April 1, 2022.

At a Glance

Live Snapshot
Market Cap$196.97M
EPS1.6400
P/E Ratio2.02
Earnings Date08/06/2026

embc

Net Interest Income

Last Annual Value

-107.30M

3-Year CAGR

-32%

5-Year CAGR

%

10-Year CAGR

%

Embecta Corp.

Embecta Corp. Competitors Analysis of Net Interest Income

EMBC · NASDAQ
CompanyNet Interest Income
CAGR 3Y
CAGR 5Y
CAGR 10Y
EMBC logo
Embecta Corp.
NASDAQ:EMBC
-107.30M
N/AN/AN/A 
-3.05M
N/AN/AN/A
CDNA logo
CareDx, Inc
NASDAQ:CDNA
9.17M
-8.2%124.7%N/A
4.15M
N/AN/AN/A
PSNL logo
Personalis, Inc.
NASDAQ:PSNL
6.95M
6.3%107.0%N/A
-12.73M
N/AN/AN/A
6.68M
N/AN/AN/A
-53.28M
N/AN/AN/A
-59.30M
N/AN/AN/A
-10.30M
N/AN/AN/A
40.24M
-22.7%146.9%N/A
Embecta Corp.

Embecta Corp. Fair Value Envelope

EMBC · NASDAQ

Our analysis suggests that EMBC has a fair value of HIDDEN per share in the Base Case projection. With shares currently trading at $3.32, this represents a potential HIDDEN relative to our calculated worth for Embecta Corp..

Intrinsic Value
Current Price: $3.32